retatrutide parkinson clinical trial ESC 2024: improves lipid and cardiovascular risk profile in Phase II Retatrutide Delivers Significant Hemoglobin A1C

The first 8-12 weeks are where the majority of discomfort happens, and it fades from there

But if it doesnt, or if it spreads, contact your healthcare provider to make sure youre not experiencing an allergic reaction to the medication

This is troubling, since those who discontinue early miss out on the long-term weight loss and health improvements that typically accrue after 3+ months of therapy

doi:10.1111/dom.14725 7

Consult with a health care provider to determine if GLP-1 agonist medications are the right fit for your specific health situation

Compounded GLP-1s are produced in FDA-regulated facilities, but the medications themselves are not FDA-approved or reviewed by the FDA for safety, effectiveness, or quality before marketing